Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotterdam Edoxaban Leaflet Evaluation in Patients after TAVI (RELEVANT-TAVI)
2019-001425-26Phase 3Completed
- Sponsor
- Thoraxcenter
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of edoxaban in aortic stenosis (AS), sponsored by Thoraxcenter. Primary endpoint: Aortic valve leaflet thickening at 3 months. Started Apr 2019; status: completed.
02
Drugs
edoxaban
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on 2019-001425-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001425-26.